The Current Ratio of Shanghai Henlius Biotech Inc (2696.HK) is 0.50.
Current Ratio compares a firm's current assets to its current liabilities to assess short-term liquidity. A ratio above 1.0 typically indicates a strong ability to meet obligations.
| Date | Value |
|---|---|
| 2024-12-31 | 0.50 |
| 2023-12-31 | 0.53 |
| 2022-12-31 | 0.44 |
| 2021-12-31 | 0.56 |
| 2020-12-31 | 0.96 |
| 2019-12-31 | 2.77 |
| 2018-12-31 | 2.04 |
| 2017-12-31 | 0.19 |